mRNA transcript diversity creates new opportunities for pharmacological intervention

Molecular Pharmacology

Volumn 81, Issue 5, 2012, Pages 620-630

  Barrie, Elizabeth S ^a   Smith, Ryan M ^a   Sanford, Jonathan C ^a   Sadee, Wolfgang ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL ESTER TRANSFER PROTEIN INHIBITOR; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT; OLIGONUCLEOTIDE; OPIATE RECEPTOR; PHTHALIC ACID; TORCETRAPIB; VASCULOTROPIN INHIBITOR; VOLTAGE DEPENDENT ANION CHANNEL; XENOBIOTIC AGENT;

ALTERNATIVE RNA SPLICING; AUTOIMMUNE DISEASE; CANCER THERAPY; DRUG DESIGN; DRUG SCREENING; DUCHENNE MUSCULAR DYSTROPHY; DYSAUTONOMIA; GENETIC VARIABILITY; IN VITRO STUDY; PRIORITY JOURNAL; RNA TRANSCRIPTION; SHORT SURVEY; SPINAL MUSCULAR ATROPHY;

ANIMALS; CALCIUM CHANNELS, L-TYPE; DRUG DESIGN; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; GENETIC VARIATION; GLUCURONOSYLTRANSFERASE; HUMANS; NEOPLASMS; NEUROMUSCULAR DISEASES; RECEPTORS, DOPAMINE D2; RECEPTORS, OPIOID, MU; RNA SPLICING; RNA, MESSENGER; TRANSCRIPTOME;

EID: 84859974894     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.111.076604     Document Type: Short Survey

References (130)

1. Akira S, Takeda K, and Kaisho T (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2:675-680. (Pubitemid 32747155)
2. Albert BJ, Sivaramakrishnan A, Naka T, Czaicki NL, and Koide K (2007) Total syntheses, fragmentation studies, and antitumor/antiproliferative activities of FR901464 and its low picomolar analogue. J Am Chem Soc 129:2648-2659. (Pubitemid 46364073)
3. Axelrod FB, Liebes L, Gold-Von Simson G, Mendoza S, Mull J, Leyne M, Norcliffe-Kaufmann L, Kaufmann H, and Slaugenhaupt SA (2011) Kinetin improves IKBKAP mRNA splicing in patients with familial dysautonomia. Pediatr Res 70:480-483.
4. Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, Komajda M, Lopez- Sendon J, Mosca L, Tardif JC, Waters DD, et al. (2007) Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 357:2109-2122. (Pubitemid 350146106)
5. Bauman JA, Li SD, Yang A, Huang L, and Kole R (2010) Anti-tumor activity of splice-switching oligonucleotides. Nucleic Acids Res 38:8348-8356.
6. Bertolino A, Fazio L, Caforio G, Blasi G, Rampino A, Romano R, Di Giorgio A, Taurisano P, Papp A, Pinsonneault J, et al. (2009) Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia. Brain 132:417-425.
7. Bertolino A, Taurisano P, Pisciotta NM, Blasi G, Fazio L, Romano R, Gelao B, Lo Bianco L, Lozupone M, Di Giorgio A, et al. (2010) Genetically determined measures of striatal D2 signaling predict prefrontal activity during working memory performance. PLoS One 5:e9348.
8. Blasi G, Lo Bianco L, Taurisano P, Gelao B, Romano R, Fazio L, Papazacharias A, Di Giorgio A, Caforio G, Rampino A, et al. (2009) Functional variation of the dopamine D2 receptor gene is associated with emotional control as well as brain activity and connectivity during emotion processing in humans. J Neurosci 29:14812-14819.
9. Borroto-Escuela DO, Romero-Fernandez W, Tarakanov AO, Marcellino D, Ciruela F, Agnati LF, and Fuxe K (2010) Dopamine D2 and 5-hydroxytryptamine 5-HT(2A) receptors assemble into functionally interacting heteromers. Biochem Biophys Res Commun 401:605-610.
10. Bosma PJ, Chowdhury JR, Bakker C, Gantla S, de Boer A, Oostra BA, Lindhout D, Tytgat GN, Jansen PL, and Oude Elferink RP (1995) The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 333:1171-1175.
11. Boukouvala S and Sim E (2005) Structural analysis of the genes for human arylamine N-acetyltransferases and characterisation of alternative transcripts. Basic Clin Pharmacol Toxicol 96:343-351. (Pubitemid 40676587)
12. Bouvier M (2001) Oligomerization of G-protein-coupled transmitter receptors. Nat Rev Neurosci 2:274-286.
13. Burns K, Janssens S, Brissoni B, Olivos N, Beyaert R, and Tschopp J (2003) Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J Exp Med 197:263-268. (Pubitemid 36152320)
14. Butcher NJ, Arulpragasam A, Goh HL, Davey T, and Minchin RF (2005) Genomic organization of human arylamine N-acetyltransferase type I reveals alternative promoters that generate different 5′-UTR splice variants with altered translational activities. Biochem J 387:119-127. (Pubitemid 40524081)
15. Cañete JD, Albaladejo C, Hernández MV, Laínez B, Pinto JA, Ramírez J, López- Armada MJ, Rodríguez-Cros JR, Engel P, Blanco FJ, et al. (2011) Clinical significance of high levels of soluble tumour necrosis factor-alpha receptor-2 produced by alternative splicing in rheumatoid arthritis: a longitudinal prospective cohort study. Rheumatology (Oxford) 50:721-728.
16. Castle JC, Zhang C, Shah JK, Kulkarni AV, Kalsotra A, Cooper TA, and Johnson JM (2008) Expression of 24,426 human alternative splicing events and predicted cis regulation in 48 tissues and cell lines. Nat Genet 40:1416-1425.
17. Castro SW and Strange PG (1993) Differences in the ligand binding properties of the short and long versions of the D2 dopamine receptor. J Neurochem 60:372-375. (Pubitemid 23006743)
18. Centonze D, Gubellini P, Usiello A, Rossi S, Tscherter A, Bracci E, Erbs E, Tognazzi N, Bernardi G, Pisani A, et al. (2004) Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum. Neuroscience 129:157-166. (Pubitemid 39360951)
19. Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, and Simmons DL (2002) COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 99:13926-13931. (Pubitemid 35215482)
20. Chang WH, Liu TC, Yang WK, Lee CC, Lin YH, Chen TY, and Chang JG (2011) Amiloride modulates alternative splicing in leukemic cells and resensitizes Bcr- AblT315I mutant cells to imatinib. Cancer Res 71:383-392.
21. Chen YC, Yuo CY, Yang WK, Jong YJ, Lin HH, Chang YS, and Chang JG (2008) Extracellular pH change modulates the exon 7 splicing in SMN2 mRNA. Mol Cell Neurosci 39:268-272.
22. Cirak S, Arechavala-Gomeza V, Guglieri M, Feng L, Torelli S, Anthony K, Abbs S, Garralda ME, Bourke J, Wells DJ, et al. (2011) Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, doseescalation study. Lancet 378:595-605.
23. Cooper TA, Wan L, and Dreyfuss G (2009) RNA and disease. Cell 136:777-793.
24. de la Grange P, Gratadou L, Delord M, Dutertre M, and Auboeuf D (2010) Splicing factor and exon profiling across human tissues. Nucleic Acids Res 38:2825-2838.
25. DeKeyser JG, Laurenzana EM, Peterson EC, Chen T, and Omiecinski CJ (2011) Selective phthalate activation of naturally occurring human constitutive androstane receptor splice variants and the pregnane X receptor. Toxicol Sci 120:381-391.
26. Desmet FO, Hamroun D, Lalande M, Collod-Béroud G, Claustres M, and Béroud C (2009) Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 37:e67.
27. Dessí M, Motti C, Cortese C, Leonardis E, Giovannini C, Federici G, and Piemonte F (1997) Alternative splicing of human plasma cholesteryl ester transfer protein mRNA in Caco-2 cells and its modulation by oleic acid. Mol Cell Biochem 177:107-112. (Pubitemid 27522364)
28. Ehmer U, Vogel A, Schütte JK, Krone B, Manns MP, and Strassburg CP (2004) Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4. Hepatology 39:970-977. (Pubitemid 38428936)
29. Elmhurst JL, Xie Z, O'Dowd BF, and George SR (2000) The splice variant D3nf reduces ligand binding to the D3 dopamine receptor: evidence for heterooligomerization. Brain Res Mol Brain Res 80:63-74. (Pubitemid 30612438)
30. Fan T, Varghese G, Nguyen T, Tse R, O'Dowd BF, and George SR (2005) A role for the distal carboxyl tails in generating the novel pharmacology and G protein activation profile of mu and delta opioid receptor hetero-oligomers. J Biol Chem 280:38478-38488. (Pubitemid 43853746)
31. Farde L, Nordström AL, Wiesel FA, Pauli S, Halldin C, and Sedvall G (1992) Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Arch Gen Psychiatry 49:538-544.
32. Faustino NA and Cooper TA (2003) Pre-mRNA splicing and human disease. Genes Dev 17:419-437. (Pubitemid 36258756)
33. Furumai R, Uchida K, Komi Y, Yoneyama M, Ishigami K, Watanabe H, Kojima S, and Yoshida M (2010) Spliceostatin A blocks angiogenesis by inhibiting global gene expression including VEGF. Cancer Sci 101:2483-2489.
34. Gabanella F, Butchbach ME, Saieva L, Carissimi C, Burghes AH, and Pellizzoni L (2007) Ribonucleoprotein assembly defects correlate with spinal muscular atrophy severity and preferentially affect a subset of spliceosomal snRNPs. PLoS One 2:e921.
35. Geib T and Hertel KJ (2009) Restoration of full-length SMN promoted by adenoviral vectors expressing RNA antisense oligonucleotides embedded in U7 snRNAs. PLoS One 4:e8204.
36. Ghigna C, De Toledo M, Bonomi S, Valacca C, Gallo S, Apicella M, Eperon I, Tazi J, and Biamonti G (2010) Pro-metastatic splicing of Ron proto-oncogene mRNA can be reversed: therapeutic potential of bifunctional oligonucleotides and indole derivatives. RNA Biol 7:495-503.
37. Girard H, Lévesque E, Bellemare J, Journault K, Caillier B, and Guillemette C (2007) Genetic diversity at the UGT1 locus is amplified by a novel 3′ alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity. Pharmacogenet Genomics 17:1077-1089. (Pubitemid 351339492)
38. Giros B, Sokoloff P, Martres MP, Riou JF, Emorine LJ, and Schwartz JC (1989) Alternative splicing directs the expression of two D2 dopamine receptor isoforms. Nature 342:923-926. (Pubitemid 20021338)
39. Goemans NM, Tulinius M, van den Akker JT, Burm BE, Ekhart PF, Heuvelmans N, Holling T, Janson AA, Platenburg GJ, Sipkens JA, et al. (2011) Systemic administration of PRO051 in Duchenne's muscular dystrophy. N Engl J Med 364:1513-1522.
40. Gong QH, Cho JW, Huang T, Potter C, Gholami N, Basu NK, Kubota S, Carvalho S, Pennington MW, Owens IS, et al. (2001) Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics 11:357-368. (Pubitemid 32537410)
41. Gorman L, Mercatante DR, and Kole R (2000) Restoration of correct splicing of thalassemic beta-globin pre-mRNA by modified U1 snRNAs. J Biol Chem 275: 35914-35919.
42. Gorman L, Suter D, Emerick V, Schümperli D, and Kole R (1998) Stable alteration of pre-mRNA splicing patterns by modified U7 small nuclear RNAs. Proc Natl Acad Sci USA 95:4929-4934. (Pubitemid 28208527)
43. Gray NK and Hentze MW (1994) Regulation of protein synthesis by mRNA structure. Mol Biol Rep 19:195-200.
44. Graziewicz MA, Tarrant TK, Buckley B, Roberts J, Fulton L, Hansen H, Ørum H, Kole R, and Sazani P (2008) An endogenous TNF-alpha antagonist induced by splice-switching oligonucleotides reduces inflammation in hepatitis and arthritis mouse models. Mol Ther 16:1316-1322. (Pubitemid 351866064)
45. Harahap IS, Saito T, San LP, Sasaki N, Gunadi, Nurputra DK, Yusoff S, Yamamoto T, Morikawa S, Nishimura N, et al. (2012) Valproic acid increases SMN2 expression and modulates SF2/ASF and hnRNPA1 expression in SMA fibroblast cell lines. Brain Dev 34:213-222.
46. Harper SJ and Bates DO (2008) VEGF-A splicing: the key to anti-angiogenic therapeutics? Nat Rev Cancer 8:880-887.
47. Hartmann L, Neveling K, Borkens S, Schneider H, Freund M, Grassman E, Theiss S, Wawer A, Burdach S, Auerbach AD, et al. (2010) Correct mRNA processing at a mutant TT splice donor in FANCC ameliorates the clinical phenotype in patients and is enhanced by delivery of suppressor U1 snRNAs. Am J Hum Genet 87:480-493.
48. Hua Y, Sahashi K, Hung G, Rigo F, Passini MA, Bennett CF, and Krainer AR (2010) Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model. Genes Dev 24:1634-1644.
49. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, et al. (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335-2342. (Pubitemid 38702844)
50. Inazu A, Quinet EM, Wang S, Brown ML, Stevenson S, Barr ML, Moulin P, and Tall AR (1992) Alternative splicing of the mRNA encoding the human cholesteryl ester transfer protein. Biochemistry 31:2352-2358.
51. Incitti T, De Angelis FG, Cazzella V, Sthandier O, Pinnarò C, Legnini I, and Bozzoni I (2010) Exon skipping and duchenne muscular dystrophy therapy: selection of the most active U1 snRNA antisense able to induce dystrophin exon 51 skipping. Mol Ther 18:1675-1682.
52. Janssens S, Burns K, Tschopp J, and Beyaert R (2002) Regulation of interleukin-1- and lipopolysaccharide-induced NF-kappaB activation by alternative splicing of MyD88. Curr Biol 12:467-471. (Pubitemid 34248892)
53. Kagimoto M, Heim M, Kagimoto K, Zeugin T, and Meyer UA (1990) Multiple mutations of the human cytochrome P450IID6 gene (CYP2D6) in poor metabolizers of debrisoquine. Study of the functional significance of individual mutations by expression of chimeric genes. J Biol Chem 265:17209-17214.
54. Kaida D, Motoyoshi H, Tashiro E, Nojima T, Hagiwara M, Ishigami K, Watanabe H, Kitahara T, Yoshida T, Nakajima H, et al. (2007) Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA. Nat Chem Biol 3:576-583. (Pubitemid 47294395)
55. Kan Z, Rouchka EC, Gish WR, and States DJ (2001) Gene structure prediction and alternative splicing analysis using genomically aligned ESTs. Genome Res 11:889-900. (Pubitemid 32447871)
56. Kapur S, Zipursky R, Jones C, Remington G, and Houle S (2000) Relationship between dopamine D(2) occupancy, clinical response, and side effects: a doubleblind PET study of first-episode schizophrenia. Am J Psychiatry 157:514-520. (Pubitemid 30191189)
57. Karpa KD, Lin R, Kabbani N, and Levenson R (2000) The dopamine D3 receptor interacts with itself and the truncated D3 splice variant d3nf: D3-D3nf interaction causes mislocalization of D3 receptors. Mol Pharmacol 58:677-683.
58. Keren H, Donyo M, Zeevi D, Maayan C, Pupko T, and Ast G (2010) Phosphatidylserine increases IKBKAP levels in familial dysautonomia cells. PLoS One 5:e15884.
59. Khan ZU, Mrzljak L, Gutierrez A, de la Calle A, and Goldman-Rakic PS (1998) Prominence of the dopamine D2 short isoform in dopaminergic pathways. Proc Natl Acad Sci USA 95:7731-7736. (Pubitemid 28293322)
60. Kis B, Snipes JA, and Busija DW (2005) Acetaminophen and the cyclooxygenase-3 puzzle: sorting out facts, fictions, and uncertainties. J Pharmacol Exp Ther 315:1-7. (Pubitemid 41380491)
61. Kotake Y, Sagane K, Owa T, Mimori-Kiyosue Y, Shimizu H, Uesugi M, Ishihama Y, Iwata M, and Mizui Y (2007) Splicing factor SF3b as a target of the antitumor natural product pladienolide. Nat Chem Biol 3:570-575. (Pubitemid 47294394)
62. Kozak M (1989) Circumstances and mechanisms of inhibition of translation by secondary structure in eucaryotic mRNAs. Mol Cell Biol 9:5134-5142.
63. Kuzhikandathil EV and Bartoszyk GD (2006) The novel antidyskinetic drug sarizotan elicits different functional responses at human D2-like dopamine receptors. Neuropharmacology 51:873-884. (Pubitemid 44308342)
64. Lainez B, Fernandez-Real JM, Romero X, Esplugues E, Cañete JD, Ricart W, and Engel P (2004) Identification and characterization of a novel spliced variant that encodes human soluble tumor necrosis factor receptor 2. Int Immunol 16:169-177. (Pubitemid 38054638)
65. Lareau LF, Brooks AN, Soergel DA, Meng Q, and Brenner SE (2007) The coupling of alternative splicing and nonsense-mediated mRNA decay. Adv Exp Med Biol 623:190-211.
66. Lévesque E, Girard H, Journault K, Lépine J, and Guillemette C (2007) Regulation of the UGT1A1 bilirubin-conjugating pathway: role of a new splicing event at the UGT1A locus. Hepatology 45:128-138. (Pubitemid 46144372)
67. Lira ME, Loomis AK, Paciga SA, Lloyd DB, and Thompson JF (2008) Expression of CETP and of splice variants induces the same level of ER stress despite secretion efficiency differences. J Lipid Res 49:1955-1962.
68. Malmberg A, Jackson DM, Eriksson A, and Mohell N (1993) Unique binding char- acteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors. Mol Pharmacol 43:749-754. (Pubitemid 23146274)
69. Marez D, Legrand M, Sabbagh N, Lo Guidice JM, Spire C, Lafitte JJ, Meyer UA, and Broly F (1997) Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution. Pharmacogenetics 7:193-202. (Pubitemid 27290633)
70. Marsh S and McLeod HL (2004) Pharmacogenetics of irinotecan toxicity. Pharmacogenomics 5:835-843. (Pubitemid 39386752)
71. Mitcham JL, Parnet P, Bonnert TP, Garka KE, Gerhart MJ, Slack JL, Gayle MA, Dower SK, and Sims JE (1996) T1/ST2 signaling establishes it as a member of an expanding interleukin-1 receptor family. J Biol Chem 271:5777-5783. (Pubitemid 26083916)
72. Modrek B and Lee C (2002) A genomic view of alternative splicing. Nat Genet 30:13-19.
73. Modrek B, Resch A, Grasso C, and Lee C (2001) Genome-wide detection of alternative splicing in expressed sequences of human genes. Nucleic Acids Res 29:2850-2859. (Pubitemid 32685050)
74. Mori A, Maruo Y, Iwai M, Sato H, and Takeuchi Y (2005) UDP-glucuronosyltransferase 1A4 polymorphisms in a Japanese population and kinetics of clozapine glucuronidation. Drug Metab Dispos 33:672-675. (Pubitemid 40593882)
75. Moroni M, Zwart R, Sher E, Cassels BK, and Bermudez I (2006) alpha4beta2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine. Mol Pharmacol 70:755-768. (Pubitemid 44092336)
76. Moyer RA, Wang D, Papp AC, Smith RM, Duque L, Mash DC, and Sadee W (2011) Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse. Neuropsychopharmacology 36:753-762.
77. Nordström AL, Farde L, Wiesel FA, Forslund K, Pauli S, Halldin C, and Uppfeldt G (1993) Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients. Biol Psychiatry 33: 227-235. (Pubitemid 23091497)
78. O'Brien K, Matlin AJ, Lowell AM, and Moore MJ (2008) The biflavonoid isoginkgetin is a general inhibitor of Pre-mRNA splicing. J Biol Chem 283:33147-33154.
79. Palladino MA, Bahjat FR, Theodorakis EA, and Moldawer LL (2003) Anti-TNFalpha therapies: the next generation. Nat Rev Drug Discov 2:736-746.
80. Pan L, Xu J, Yu R, Xu MM, Pan YX, and Pasternak GW (2005a) Identification and characterization of six new alternatively spliced variants of the human mu opioid receptor gene, Oprm. Neuroscience 133:209-220. (Pubitemid 40694171)
81. Pan Q, Shai O, Lee LJ, Frey BJ, and Blencowe BJ (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 40:1413-1415.
82. Pan YX, Xu J, Bolan E, Moskowitz HS, Xu M, and Pasternak GW (2005b) Identification of four novel exon 5 splice variants of the mouse mu-opioid receptor gene: functional consequences of C-terminal splicing. Mol Pharmacol 68:866-875. (Pubitemid 41206043)
83. Pan YX, Xu J, Mahurter L, Bolan E, Xu M, and Pasternak GW (2001) Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene. Proc Natl Acad Sci USA 98:14084-14089. (Pubitemid 33116028)
84. Pan YX, Xu J, Xu M, Rossi GC, Matulonis JE, and Pasternak GW (2009) Involvement of exon 11-associated variants of the mu opioid receptor MOR-1 in heroin, but not morphine, actions. Proc Natl Acad Sci USA 106:4917-4922.
85. Phillips KA, Veenstra DL, Oren E, Lee JK, and Sadee W (2001) Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. Jama 286:2270-2279. (Pubitemid 33063150)
86. Pinotti M, Rizzotto L, Balestra D, Lewandowska MA, Cavallari N, Marchetti G, Bernardi F, and Pagani F (2008) U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency. Blood 111:2681-2684.
87. Poulikakos PI, Persaud Y, Janakiraman M, Kong X, Ng C, Moriceau G, Shi H, Atefi M, Titz B, Gabay MT, et al. (2011) RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E). Nature 480:387-390.
88. Pros E, Fernández-Rodríguez J, Benito L, Ravella A, Capellá G, Blanco I, Serra E, and Lázaro C (2010) Modulation of aberrant NF1 pre-mRNA splicing by kinetin treatment. Eur J Hum Genet 18:614-617.
89. Qin N, Zhang SP, Reitz TL, Mei JM, and Flores CM (2005) Cloning, expression, and functional characterization of human cyclooxygenase-1 splicing variants: evidence for intron 1 retention. J Pharmacol Exp Ther 315:1298-1305. (Pubitemid 41635418)
90. Ritter JK, Chen F, Sheen YY, Tran HM, Kimura S, Yeatman MT, and Owens IS (1992) A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J Biol Chem 267:3257-3261.
91. Schmajuk G, Sierakowska H, and Kole R (1999) Antisense oligonucleotides with different backbones. Modification of splicing pathways and efficacy of uptake. J Biol Chem 274:21783-21789.
92. Schuller AG, King MA, Zhang J, Bolan E, Pan YX, Morgan DJ, Chang A, Czick ME, Unterwald EM, Pasternak GW, et al. (1999) Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1. Nat Neurosci 2:151-156. (Pubitemid 30491315)
93. Sharief MK and Hentges R (1991) Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N Engl J Med 325: 467-472.
94. Shetty RS, Gallagher CS, Chen YT, Hims MM, Mull J, Leyne M, Pickel J, Kwok D, and Slaugenhaupt SA (2011) Specific correction of a splice defect in brain by nutritional supplementation. Hum Mol Genet 20:4093-4101.
95. Sierakowska H, Sambade MJ, Agrawal S, and Kole R (1996) Repair of thalassemic human beta-globin mRNA in mammalian cells by antisense oligonucleotides. Proc Natl Acad Sci USA 93:12840-12844. (Pubitemid 26382730)
96. Singh NN, Shishimorova M, Cao LC, Gangwani L, and Singh RN (2009) A short antisense oligonucleotide masking a unique intronic motif prevents skipping of a critical exon in spinal muscular atrophy. RNA Biol 6:341-350.
97. Skordis LA, Dunckley MG, Yue B, Eperon IC, and Muntoni F (2003) Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts. Proc Natl Acad Sci USA 100:4114-4119. (Pubitemid 36418166)
98. Smith RM and Sadee W (2011) Synaptic signaling and aberrant RNA splicing in autism spectrum disorders. Front Synaptic Neurosci 3:1.
99. Soret J, Bakkour N, Maire S, Durand S, Zekri L, Gabut M, Fic W, Divita G, Rivalle C, Dauzonne D, et al. (2005) Selective modification of alternative splicing by indole derivatives that target serine-arginine-rich protein splicing factors. Proc Natl Acad Sci USA 102:8764-8769. (Pubitemid 40862809)
100. Stoilov P, Lin CH, Damoiseaux R, Nikolic J, and Black DL (2008) A high-throughput screening strategy identifies cardiotonic steroids as alternative splicing modulators. Proc Natl Acad Sci USA 105:11218-11223.
101. Tang ZZ, Liang MC, Lu S, Yu D, Yu CY, Yue DT, and Soong TW (2004) Transcript scanning reveals novel and extensive splice variations in human l-type voltagegated calcium channel, Cav1.2 alpha1 subunit. J Biol Chem 279:44335-44343. (Pubitemid 39430838)
102. Taniguchi-Ikeda M, Kobayashi K, Kanagawa M, Yu CC, Mori K, Oda T, Kuga A, Kurahashi H, Akman HO, DiMauro S, et al. (2011) Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy. Nature 478: 127-131.
103. Tate SK, Depondt C, Sisodiya SM, Cavalleri GL, Schorge S, Soranzo N, Thom M, Sen A, Shorvon SD, Sander JW, et al. (2005) Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin. Proc Natl Acad Sci USA 102:5507-5512. (Pubitemid 40530288)
104. Thompson CH, Kahlig KM, and George AL Jr (2011) SCN1A splice variants exhibit divergent sensitivity to commonly used antiepileptic drugs. Epilepsia 52:1000-1009.
105. Usiello A, Baik JH, Rougé-Pont F, Picetti R, Dierich A, LeMeur M, Piazza PV, and Borrelli E (2000) Distinct functions of the two isoforms of dopamine D2 receptors. Nature 408:199-203.
106. van Deutekom JC, Janson AA, Ginjaar IB, Frankhuizen WS, Aartsma-Rus A, Bremmer- Bout M, den Dunnen JT, Koop K, van der Kooi AJ, Goemans NM, et al. (2007) Local dystrophin restoration with antisense oligonucleotide PRO051. N Engl J Med 357:2677-2686.
107. Varey AH, Rennel ES, Qiu Y, Bevan HS, Perrin RM, Raffy S, Dixon AR, Paraskeva C, Zaccheo O, Hassan AB, et al. (2008) VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy. Br J Cancer 98:1366-1379. (Pubitemid 351543576)
108. Vickers TA, Zhang H, Graham MJ, Lemonidis KM, Zhao C, and Dean NM (2006) Modification of MyD88 mRNA splicing and inhibition of IL-1beta signaling in cell culture and in mice with a 2′-O-methoxyethyl-modified oligonucleotide. J Immunol 176:3652-3661. (Pubitemid 43364012)
109. Vitte J, Fassier C, Tiziano FD, Dalard C, Soave S, Roblot N, Brahe C, Saugier-Veber P, Bonnefont JP, and Melki J (2007) Refined characterization of the expression and stability of the SMN gene products. Am J Pathol 171:1269-1280. (Pubitemid 47582900)
110. Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, Horvath S, Mill J, Cantor RM, Blencowe BJ, and Geschwind DH (2011) Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474:380-384.
111. Wang D, Papp AC, Binkley PF, Johnson JA, and Sadée W (2006) Highly variable mRNA expression and splicing of L-type voltage-dependent calcium channel alpha subunit 1C in human heart tissues. Pharmacogenet Genomics 16:735-745. (Pubitemid 44454868)
112. Wang D, Para MF, Koletar SL, and Sadee W (2011) Human N-acetyltransferase 1*10 and*11 alleles increase protein expression through distinct mechanisms and associate with sulfamethoxazole-induced hypersensitivity. Pharmacogenet Genomics 21:652-664.
113. Wang D, Sun X, Bohn LM, and Sadée W (2005) Opioid receptor homo- and heterodimerization in living cells by quantitative bioluminescence resonance energy transfer. Mol Pharmacol 67:2173-2184. (Pubitemid 41007796)
114. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, and Burge CB (2008) Alternative isoform regulation in human tissue transcriptomes. Nature 456:470-476. (Pubitemid 352759009)
115. Wang GS and Cooper TA (2007) Splicing in disease: disruption of the splicing code and the decoding machinery. Nat Rev Genet 8:749-761.
116. Welling A, Ludwig A, Zimmer S, Klugbauer N, Flockerzi V, and Hofmann F (1997) Alternatively spliced IS6 segments of the alpha 1C gene determine the tissue-specific dihydropyridine sensitivity of cardiac and vascular smooth muscle L-type Ca2+ channels. Circ Res 81:526-532. (Pubitemid 27432739)
117. Williams JH, Schray RC, Patterson CA, Ayitey SO, Tallent MK, and Lutz GJ (2009) Oligonucleotide-mediated survival of motor neuron protein expression in CNS improves phenotype in a mouse model of spinal muscular atrophy. J Neurosci 29:7633-7638.
118. Wilton SD and Fletcher S (2005) RNA splicing manipulation: strategies to modify gene expression for a variety of therapeutic outcomes. Curr Gene Ther 5:467-483. (Pubitemid 41448352)
119. Wirth B, Brichta L, and Hahnen E (2006) Spinal muscular atrophy: from gene to therapy. Semin Pediatr Neurol 13:121-131. (Pubitemid 44486827)
120. Woolard J, Wang WY, Bevan HS, Qiu Y, Morbidelli L, Pritchard-Jones RO, Cui TG, Sugiono M, Waine E, Perrin R, et al. (2004) VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res 64:7822-7835. (Pubitemid 39446915)
121. Xu J, Xu M, Hurd YL, Pasternak GW, and Pan YX (2009) Isolation and characterization of new exon 11-associated N-terminal splice variants of the human mu opioid receptor gene. J Neurochem 108:962-972.
122. Xu J, Xu M, Rossi GC, Pasternak GW, and Pan YX (2011) Identification and characterization of seven new exon 11-associated splice variants of the rat mu opioid receptor gene, OPRM1. Mol Pain 7:9.
123. Xu R, Hranilovic D, Fetsko LA, Bucan M, and Wang Y (2002) Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice. Mol Psychiatry 7:1075-1082.
124. Yang TP, Agellon LB, Walsh A, Breslow JL, and Tall AR (1996) Alternative splicing of the human cholesteryl ester transfer protein gene in transgenic mice. Exon exclusion modulates gene expression in response to dietary or developmental change. J Biol Chem 271:12603-12609. (Pubitemid 26160935)
125. Yeo G, Holste D, Kreiman G, and Burge CB (2004) Variation in alternative splicing across human tissues. Genome Biol 5:R74.
126. Young JI, Hong EP, Castle JC, Crespo-Barreto J, Bowman AB, Rose MF, Kang D, Richman R, Johnson JM, Berget S, et al. (2005) Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc Natl Acad Sci USA 102:17551-17558. (Pubitemid 41803535)
127. Yuo CY, Lin HH, Chang YS, Yang WK, and Chang JG (2008) 5-(N-ethyl-Nisopropyl)- amiloride enhances SMN2 exon 7 inclusion and protein expression in spinal muscular atrophy cells. Ann Neurol 63:26-34.
128. Zhang Y, Bertolino A, Fazio L, Blasi G, Rampino A, Romano R, Lee ML, Xiao T, Papp A, Wang D, et al. (2007) Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc Natl Acad Sci USA 104:20552-20557.
129. Zhang Z, Lotti F, Dittmar K, Younis I, Wan L, Kasim M, and Dreyfuss G (2008) SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing. Cell 133:585-600. (Pubitemid 351636302)
130. Zuker M (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31:3406-3415.